The Board of Directors of Ind-Swift Laboratories Ltd at its meeting held today, i.e. 8th January, 2020 has approved the allotment of 1,15,17,670 Equity shares of face value of Rs. 10 each to EC Special Situations Fund (40,31,184 shares), Edelweiss India Special Situations Fund II (61,60,802 shares) and EISAF II Onshore Fund (13,25,684 shares).
The above Allotment has been made pursuant to exercise of right by OCD holders for conversion of 1,15,17,670 OCDs of face value of Rs. 10/- each into equivalent number of Equity Shares of Rs. 10/- each, issued at an price of Rs. 65.50 per OCD including a premium of Rs. 55.50 per OCD on 25th July, 2018.
These Equity shares so allotted will be listed on BSE Limited and National Stock Exchange of India Limited.
Pursuant to the aforesaid allotment, the paid up share capital of the Company stands increased from Rs. 47,56,91,900 divided into 4,75,69,190 Equity Shares of Rs. 10/- each to Rs. 59,08,68,600 divided into 5,90,86,860 of Rs. 10/- each.
Shares of IND-SWIFT LABORATORIES LTD. was last trading in BSE at Rs.25.8 as compared to the previous close of Rs. 25.45. The total number of shares traded during the day was 18765 in over 77 trades.
The stock hit an intraday high of Rs. 26.7 and intraday low of 25.3. The net turnover during the day was Rs. 494410.